Bioshare Polymer Amniotic Membrane Dissolving Device
Ocular Wounds and Injuries (e.g., corneal injuries, burns)
Pre-clinical/FeasibilityActive
Key Facts
Indication
Ocular Wounds and Injuries (e.g., corneal injuries, burns)
Phase
Pre-clinical/Feasibility
Status
Active
Company
About Diopter Technologies
Diopter Technologies is a private, pre-revenue medical device innovator founded in 2021 and based in San Francisco. The company is pioneering a novel platform that integrates drug delivery and regenerative biologics into advanced contact lens and dissolving polymer devices for treating ocular surface disorders. Its lead programs include the PrismX drug-eluting contact lens and the Bioshare dissolving amniotic membrane device, with at least one clinical study recently completed. Diopter is positioning itself to address significant unmet needs in corneal repair and chronic eye disease treatment, aiming to improve patient compliance and clinical outcomes.
View full company profile